MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection

Journal of Virology

Volumn 71, Issue 10, 1997, Pages 7609-7618

  Henning, Wilhelm ^a   Rohaly, Gabor ^a   Kolzau, Thomas ^a   Knippschild, Uwe ^a,b   Maacke, Heiko ^a   Deppert, Wolfgang ^a  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEASOME;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; COMPLEX FORMATION; CYTOLYSIS; ENZYME DEGRADATION; HELPER CELL; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REGULATOR GENE; SIMIAN VIRUS 40; TARGET CELL; VIRUS INFECTION; VIRUS TRANSFORMATION;

EID: 0030865801     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.10.7609-7618.1997     Document Type: Article

References (81)

1. Avantaggiati, M. L., M. Carbone, A. Graessmann, Y. Nakatani, B. Howard, and A. S. Levine. 1996. The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co-activator, p300. EMBO J. 15:2236-2248.
2. Barak, Y., and M. Oren. 1992. Enhanced hinding of a 95 kDa protein to p53 in cells undergoing p53-mediatcd growth arrest. EMBO J. 11:2115-2121
3. Barak, Y., T. Juven, R. Haffner, and M. Oren. 1993. mdm2 expression is induced by wild-type p53 activity. EMBO J. 12:461-468.
4. Barak, Y., E. Gottlieb, T. Juven-Gershon, and M. Oren. 1994. Regulation of mdm2 expresion by p53: alternative promoters produce transcripts with nonidentical translation potential. Genes Dev. 8:1739-1749.
5. Bargonetti, J., I. Reynidottir, P. N. Friedman, and C. Prives. 1992. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes Dev. 6:1886-1898.
6. Bauer, M., E. Guhl, M. Graessmann, and A. Graessmann. 1987. Cellular mutation mediates T-antigen-positive revertant cells resistant to simian virus virus transformation by polyomavirus and adenovirus type 2. J. Virol. 61:1821-1827.
7. Berberich, S., and M. Cole. 1994. The mdm-2 oncogene is translocated and overexpressed in a murine plasmacytoma cell line expressing wild-type p53.Oncogene 9:1469-1472.
8. Bienz, B., R. Zakut-Houri, D. Givol, and M. Oren. 1984. Analysis of the gene coding for the murine cellular tumour antigen p53. EMBO J. 3:2179-2183.
9. Brown, d. R., S. Deb, R. M. Munoz, M. A. Subler, and S. P. Deb. 1993. The tumor suppressor p53 and the oncoprotein siman virus 40 T antigen bind to overlapping domains on the MDM2 protein. Mol. Cell. Biol. 13:6849-6857.
10. Buchman, A. R., L. Burnett, and P. Berg. 1986. The SV40 nucleotide se- qucnce. p. 799-823. In J. Tooze (ed.), DNA tumor viruses, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
11. Bueso-Ramos, C. E., Y. Yang, E. deLeon, P. McCown, S. A. Stass, and M. Albitar. 1993. The human MDM-2 oncogene is overexpressed in leukemias. Blood 82:2617-2623.
12. Chen, J., V. Marechal, and A. J. Levine. 1993. Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 13:4107-4114.
13. Cordon-Cardo, C., E. Latres, M. Drobnjak, M. R. Oliva, D. Pollack, J. M. Woodruff, V. Marechal, J. Chen, M. F. Brennan, and A. J. Levine. 1994. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res. 54:794-799.
14. Deppert, W., and M. Haug. 1986. Evidence for free and metabolically stable p53 protein in nuclear subtractions of simian virus 40-transformed cells. Mol. Cell. Biol. 6:2233-2240.
15. Deppert, W., M. Hang, and T. Steinmayer. 1987. Modulation of p53 protein expression during cellular transformation with simian virus 40. Mol. Cell. Biol. 7:4453-4463.
16. Deppert, W., T. Steinmayer, and W. Richter. 1989. Cooperation of SV40 large T antigen and the cellular protein p53 in maintenance of transformation. Oncogene 4:1103-1110.
17. Deppert, W., M. Kurth, M. Graessmann, A. Graessmann, and U. Knippschild. 1991. Altered phosphorylation at specific sites confers a mutant phenotype to SV40 wild-type large T antigen in a flat revenant of SV40 transformed cells. Oncogene 6:1931-1938.
18. Deppert, W. 1996. Binding of MAR-DNA elements by mutant p53: possible implications for its oncogenic functions. J. Cell. Biochem. 62:172-180.
19. Dittmer, D., S. Pati, G. Zambetti, S. Chu, A. K. Teresky, M. Moore, C. Finlay, and A. J. Levine. 1993. Gain of function mutations in p53. Nat. Genet. 4:42-46.
20. Elenbaas, B., M. Dobbelstein, J. Roth, and A. Levine. 1996. The MDM2 oncoprotein binds specifically to RNA through its RING finger domain. Mol. Med. 2:439-451.
21. Fakharzadeh, S. S., S. P. Trusko, and D. L. George. 1991. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J. 10:1565-569.
22. Fanning, E., C. Burger, and E. G. Gurney. 1981. Comparison of T antigen-associated host phosphoproteins from SV40-infected and -transformed cells of different species. J. Gen. Virol. 55:367-378.
23. Fanning, E. 1992. Simian virus 40 large T antigen: the puzzle, the pieces, and the emerging picture. J. Virol. 66:1289-1293.
24. Finlay, C. A. 1993. The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth. Mol. Cell. Biol. 13:301-306.
25. Freeman, A. E., H. J. Igel, and P. J. Price. 1975. Carcinogenesis in vitro. I. In vitro transformation of rat embryo cells: correlations with the known tumorigenic activity of chemicals in rodents. In vitro (Rockville) 2:107-116.
26. Haines, D. S., J. E. Landers, L. J. Engle, and D. L. George. 1994. Physical and functional interaction between wild-type p53 and mdm2 proteins. Mol. Cell. Biol. 14:1171-1178.
27. Halevy, O., D. Michalovitz, and M. Oren. 1990. Different tumor-derived p53 mutants exhibit distinct biological activities. Science 250:113-116.
28. Harlow, E., L. V. Crawford, D. C. Pim, and N. M. Williamson. 1981. Monoclonal antibodies specific for simian virus 40 tumor antigens. J. Virol. 39: 861-869.
29. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387:296-299.
30. Henning, W., P. Lecane, and W. Deppert. Unpublished data.
31. Henning, W., G. Rohaly, and W. Deppert. Unpublished data.
32. Hoess, A., I. Moarefi, K. H. Scheidtmann, L. J. Cisek, J. L. Corden, I. Dornreiter, A. K, Arthur, and E. Fanning. 1990. Altered phosphorylation pattern of simian virus 40 T antigen expressed in insect cells by using a baculovirus vector. J. Virol. 64:4799-4807.
33. Hoppe-Seyler, F., and K. Butz. 1995. Molecular mechanisms of virus-induced carcinogenesis: the interaction of viral factors with cellular tumor suppressor proteins. J. Mol. Med. 73:529-538.
34. Jones, S. N., A. E. Roe, L. A. Donehower, and A. Bradley. 1995. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378: 206-208.
35. Juven, T., Y. Barak, A. Zauberman, D. L. George, and M. Oren. 1993. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene 8:3411-3416.
36. Kit, S., D. S. Dubbs, R. A. DeTorres, and J. L. Melnick. 1965. Enhanced thymidine kinase activity following infection of green monkey kidney cells by simian adenoviruses. simian papovavirus SV40, and an adenovirus-SV40 "hybrid." Virology 27:453-457.
37. Knippschild, U., J. Kiefer, T. Patschinsky, and W. Deppert. 1991. Phenotype-specific phosphorylation of simian virus 40 tsA mutant large T antigens in tsA N-type and A-type transformants. J. Virol. 65:4414-4423.
38. Kolzau, T. 1996. Ph.D. thesis. University of Hamburg, Hamburg, Germany.
39. Kubbutat, M. H., S. N. Jones, and K. H. Vousden. 1997. Regulation of p53 stability by Mdm2. Nature 387:299-303.
40. Ladanyi, M., R. Lewis, S. C. Jhanwar, W. Gerald, A. G. Huvos, and J. H. Healey. 1995. MDM2 and CDK4 gene amplification in Ewing's sarcoma. J. Pathol. 175:211-217.
41. Landers, J. E., D. S. Haines, J. F. Strauss III, and D. L. George. 1994. Enhanced translation: a novel mechanism of mdm2 oncogene overexpression identified in human tumor cells. Oncogene 9:2745-2750.
42. Lane, D. P., C. W. Stephen, C. A. Midgley, A. Sparks, T. R. Hupp, D. A. Daniels, R. Greaves, A. Reid, B. Vojtesek, and S. M. Picksley. 1996. Epitope analysis of the murine p53 tumour suppressor protein. Oncogene 12:2461-2466.
43. Leach, F. S., T. Tokino, P. Meltzer, M. Burrell, O. J. D, S. Smith, D. E. Hill, D. Sidransky, K. W. Kinzler, and B. Vogelstein. 1993. p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res. 53:2231-2234.
44. Levine, A. J. 1990. The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses. Virology 177:419-426.
45. Luna, R. M. D., D. S. Wagner, and G. Lozano. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378: 203-206.
46. Manfredi, J. J., and C. Prives. 1994. The transforming activity of simian virus 40 large tumor antigen. Biochim. Biophys. Acta Rev. Cancer 1198:65-83.
47. Marechal, V., B. Elenbaas, J. Piette, J. Nicolas, and A. J. Levine. 1994. The ribosomal L5 protein is associated with MDM2 and MDM2-p53 complexes. Mol. Cell. Biol. 14:7414-7420.
48. Martin, K., D. Trouche, C. Hagemeier, T. S. Sorensen, N. B. La Thangue, and T. Kouzarides. 1995. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375:691-694.
49. Michalovitz, D., D, Eliyahu, and M. Oren. 1986. Overproduction of protein p53 contributes to simian virus 40-mediated transformation. Mol. Cell. Biol. 6:3531-3536.
50. Michalovitz, D., O. Halevy, and M. Oren. 1990. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671-680.
51. Mietz, J. A., T. Unger, J. M. Huibregtse, and P. M. Howley. 1992. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J. 11:5013-5020.
52. Momand, J., G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
53. Montano, X., and D. P. Lane. 1984. Monoclonal antibody to simian virus 40 small t. J. Virol. 51:760-767.
54. Mosner, J., and W. Deppert. 1994. p53 and mdm2 are independently expressed during cellular proliferation. Oncogene 9:3321-3328.
55. Mosner, J., T. Mummenbrauer, C. Bauer, G. Szakiel, F. Grosse, and W. Deppert. 1995. Negative feedback regulation of wild-type p53 biosynthesis. EMBO J. 14:4442-4449.
56. Mumby, M. C., and G. Walter. 1991. Protein phosphatases and DNA tumor viruses: transformation through the back door? Cell. Regul. 2:589-598.
57. Oliner, J. D., K. W. Kinzler, P. S. Meltzer, D. L. George, and B. Vogelstein. 1992. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80-83.
58. Oliner, J. D., J. A. Pietenpol, S. Thiagalingam, J. Gyuris, K. W. Kinzler, and B. Vogelstein. 1993. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362:857-860.
59. Olson, D. C., V. Marechal, J. Momand, J. Chen, C. Romocki, and A. J. Levine. 1993. Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes. Oncogene 8:2353-2360.
60. Otto, A., and W. Deppert. 1993. Upregulation of mdm-2 expression in Meth A tumor cells tolerating wild-type p53. Oncogene 8:2591-2603.
61. Picksley, S. M., and D. P. Lane. 1993. The p53-mdm2 autoregulatory feedback loop: a paradigm for the regulation of growth control by p53? Bioessays 15:689-690.
62. Picksley, S. M., B. Vojtesek, A. Sparks, and D. P. Lane. 1994. Immunochemical analysis of the interaction of p53 with MDM2: fine mapping of the MDM2 binding site on p53 using synthetic peptides. Oncogene 9:2523-2529.
63. Picksley, S. M., B. Vojtesek, A. Sparks, and D. P. Lane. 1994. Immunochemical analysis of the interaction of p53 and MDM2-fine mapping of the MDM2 binding site on p53, abstr. 118. In Program and Abstracts of the 7th p53 Workshop.
64. Prives, C. 1990. The replication functions of SV40 T antigen are regulated by phosphorylation. Cell 61:735-738.
65. Prives, C., J. Bargonetti, P. N. Friedman, J. J. Manfredi, and E. H. Wang. 1991. Functional consequences of the interactions of the p53 tumor suppressor protein and SV40 large tumor antigen. Cold Spring Harbor Symp. Quant. Biol. 56:227-235.
66. Reifenberger, G., L. Liu, K. Ichimura, E. Schmidt, and V. P. Collins. 1993. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res. 53:2736-2739.
67. Scheidtmann, K. H., B. Echle, and G. Walter. 1982. Simian virus 40 large T antigen is phosphorylated at multiple sites clustered in two separate regions. J. Virol. 44:116-133.
68. Scheidtmann, K. H. 1989. SV40 large T antigen induces a protein kinase responsible for phosphorylation of the cellular protein p53. Curr. Top. Microbiol. Immunol. 144:85-88.
69. Scheidtmann, K. H., M. Buck, J. Schneider, D. Kalderon, E. Fanning, and A. E. Smith. 1991. Biochemical characterization of phosphorylation site mutants of simian virus 40 large T antigen: evidence for interaction between amino- and carboxy-terminal domains. J. Virol. 65:1479-1490.
70. Segawa, K., A. Minowa, K. Sugasawa, T. Takano, and F. Hanaoka. 1993. Abrogation of p53-mediated transactivation by SV40 large T antigen. Oncogene 8:543-548.
71. Stürzbecher, H. W., M. Montenarh, and R. Henning. 1987. Enhanced protein phosphorylation in SV40-transformed and -infected cells. Virology 160: 445-455.
72. Tack, L. C., and J. H. Wright. 1992. Altered phosphorylation of free and bound forms of monkey p53 and simian virus 40 large T antigen during lytic infection. J. Virol. 66:1312-1320.
73. Tiemann, F., and W. Deppert. 1994. Immortalization of BALB/c mouse embryo fibroblasts alters SV40 large T antigen interactions with the tumor suppressor p53 and results in a reduced SV40 transformation-efiiciency. Oncogene 9:1907-1915.
74. Tiemann, F., J. Zerrahn, and W. Deppert. 1995. Cooperation of simian virus 40 large and small T antigens in metabolic stabilization of tumor suppressor p53 during cellular transformation. J. Virol. 69:6115-6121.
75. Todaro, G. J., K. Habel, and H. Green. 1965. Antigenic and cultural prop crtics of cells doubly transformed by polyoma virus and SV40. Virology 27:179-185.
76. Wang, J. Y. J., E. S. Knudsen, and P. J. Welch. 1994. The retinoblastoma tumor suppressor protein. Adv. Cancer Res. 64:25-86.
77. Wu, X., J. H. Bayle, D. Olson, and A. J. Levine. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7:1126-1132.
78. Xiao, Z. X., J. Chen, A. J. Levine, N. Modjtahedi, J. Xing, W. R. Sellers, and D. M. Livingston. 1995. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375:694-698.
79. Zambetti, G. P., and A. J. Levine. 1993. A comparison of the biological activities of wild-type and mutant p53. FASEB J. 7:855-865.
80. Zerrahn, J., and W. Deppert. 1993. Analysis of simian virus 40 small t antigen-induces progression of rat Fill cells minimally transformed by large T antigen. J. Virol. 67:1555-1563.
81. Zerrahn, J., F. Tiemann, and W. Deppert. 1996. Simian virus 40 small T antigen activates the carboxy-terminal transforming p53-binding domain of large T antigen. J. Virol. 7:6781-6789.